These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29302226)

  • 1. Minding the brain: the role of pharmacotherapy in substance-use disorder treatment.
    Elias D; Kleber HD
    Dialogues Clin Neurosci; 2017 Sep; 19(3):289-297. PubMed ID: 29302226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual differences in the neuropsychopathology of addiction.
    George O; Koob GF
    Dialogues Clin Neurosci; 2017 Sep; 19(3):217-229. PubMed ID: 29302219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders.
    Dakwar E; Nunes EV
    Curr Psychiatry Rep; 2016 Jul; 18(7):64. PubMed ID: 27222138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurobiology of cocaine addiction: implications for new pharmacotherapy.
    Kalivas PW
    Am J Addict; 2007; 16(2):71-8. PubMed ID: 17453607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. tDCS in Addiction and Impulse Control Disorders.
    Lapenta OM; Marques LM; Rego GG; Comfort WE; Boggio PS
    J ECT; 2018 Sep; 34(3):182-192. PubMed ID: 30095681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common and distinct neural targets of treatment: changing brain function in substance addiction.
    Konova AB; Moeller SJ; Goldstein RZ
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2806-17. PubMed ID: 24140399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in the pharmacotherapy of substance abuse.
    O'Brien CP
    J Consult Clin Psychol; 1996 Aug; 64(4):677-86. PubMed ID: 8803357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis.
    Koob GF
    Addiction; 2006 Sep; 101 Suppl 1():23-30. PubMed ID: 16930158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addiction.
    Naim-Feil J; Zangen A
    Handb Clin Neurol; 2013; 116():613-30. PubMed ID: 24112928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Analysis of the Outcomes of Smoking Cessation Pharmacotherapy Among Persons With Mental Health and Substance Use Disorders.
    Okoli CT; Anand V; Khara M
    J Dual Diagn; 2017; 13(1):21-28. PubMed ID: 28166473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?
    Roth RM; Brunette MF; Green AI
    Curr Psychiatry Rep; 2005 Aug; 7(4):283-91. PubMed ID: 16098282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiology for addiction medicine: From methodology to conceptualization of reward deficits.
    Stewart JL; May AC
    Prog Brain Res; 2016; 224():67-84. PubMed ID: 26822354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for alcohol-related disorders: what clinicians should know.
    Mariani JJ; Levin FR
    Harv Rev Psychiatry; 2004; 12(6):351-66. PubMed ID: 15764470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pharmacology for addiction medicine: From evidence to clinical recommendations.
    Quednow BB; Herdener M
    Prog Brain Res; 2016; 224():227-50. PubMed ID: 26822361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Craving as a core symptom in substance use disorders: epidemiology, neurobiological substrates and clinical relevance].
    Morissette A; Ouellet-Plamondon C; Jutras-Aswad D
    Sante Ment Que; 2014; 39(2):21-37. PubMed ID: 25590542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs.
    Saxon AJ; McCarty D
    Pharmacol Ther; 2005 Oct; 108(1):119-28. PubMed ID: 16055196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurobiology of substance-related addiction: findings of neuroimaging].
    Kienast T; Wrase J; Heinz A
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S68-76. PubMed ID: 18461548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug abuse and the neurovascular unit.
    Egleton RD; Abbruscato T
    Adv Pharmacol; 2014; 71():451-80. PubMed ID: 25307226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug addiction: a curable mental disorder?
    Liu JF; Li JX
    Acta Pharmacol Sin; 2018 Dec; 39(12):1823-1829. PubMed ID: 30382181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tobacco use and illicit substance use disorders: what should we have to do?].
    Karila L; Petit A; Zarmdini R; Coscas S; Lowenstein W; Reynaud M
    Presse Med; 2013 May; 42(5):795-805. PubMed ID: 23528335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.